Aditya Birla Fashion and Retail Limited 
Dealstreet

Cyril Amarchand Mangaldas assists Aditya Birla Fashion and Retail on acquisition of TCNS Clothing

ABFRL is to acquire 51% stake in TCNS by way of a share purchase from the promoters of the TCNS.

Bar & Bench

Aditya Birla Fashion and Retail Limited (ABFRL) has acquired TCNS Clothing Co. Limited. (TCNS).

As part of the transaction, ABFRL is to acquire 51% stake in TCNS by way of a share purchase from the promoters of the TCNS, followed by a conditional open offer to the TCNS’ public shareholders, and subsequent merger of the TCNS in ABFRL.

The General Corporate Practice of Cyril Amarchand Mangaldas advised on the transaction. 

The transaction team was led by Nivedita Rao (Partner & Deputy Head – Corporate), Ruetveij Pandya (Partner), Anand Jayachandran, (Partner); with support from Abhilasha Malpani (Principal Associate), Sheetal S (Senior Associate), Anushka Jain (Senior Associate), Kritika Dobhal (Associate), Ayushi Singh (Associate), Vishvas Bharadwaj (Associate), Rohit Maheshwary (Associate), Ipkshita Singh (Associate) and Alok Agrawal (Associate).

Avaantika Kakkar (Partner and Head-Competition), Kirthi Srinivas (Partner), Shivani Sathe (Associate), Shruti Khaitan (Associate) and Vanya Agarwal (Associate) assisted in the Competition law related advisory.

Pallavi Rao (Partner), Shatrajit Banerji (Principal Associate) and Shubhaankar Ray (Associate) assisted in the IP related advisory.

If you would like your Deals, Columns, Press Releases to be published on Bar & Bench, please fill in the form available here.

RPNLU Prayagraj finance controller removed after refusing VC’s ₹70,000 academic incentive

Preaching religion without prior permission can lead to cancellation of OCI registration: Madras High Court

Two IIULER Goa students die in motor accident; University to hold end-sems as scheduled

Here's what Jio Platforms paid in legal fees for its ₹30,000 crore IPO

Can you justify this loot? Supreme Court slams hospitals, government for 1,000% mark-up on cancer drugs

SCROLL FOR NEXT